Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers

Cancer Letters

Volumn 137, Issue 1, 1999, Pages 53-60

  Kihara, Masako ^a   Kihara, Masahiro ^a   Noda, Kazumasa ^a  

^a KANAGAWA CANCER CENTER   (Japan)

Author keywords

GSTM1; GSTP1; Lung cancer; Polymorphism; Smoking

Indexed keywords

ARTICLE; CANCER RISK; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; JAPAN; LUNG CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; ALLELES; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SMOKING;

EID: 0032926768     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00337-1     Document Type: Article

References (37)

1. Alexandrie A.K., Sundberg M.I., Seidegard J., Tornling G., Rannug A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis. 15:1994;1785-1790.
2. Awasthi Y.C., Sharma R., Singhal S.S. Human glutathione S-transferases. Int. J. Biochem. 26:1994;295-308.
3. Bell D.A., Taylor J.A., Paulson D.F., Robertson C.N., Mohler J.L., Lucier G.W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85:1993;1159-1164.
4. Board P.G., Webb G.C., Coggan M. Isolation of cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann. Hum. Genet. 53:1989;205-213.
5. Board P., Coggan M., Johnston P., Ross V., Suzuki T. Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol. Ther. 48:1990;357-369.
6. Brockmoller J., Kerb R., Drakoulis N., Nitz M., Roots I. Genotype and phenotype of glutathione S-transferase class mu isozymes μ and φ in lung cancer patients and controls. Cancer Res. 53:1993;1004-1011.
7. Garcia-Closas M., Kelsey K.T., Wiencke J.K., Xu X., Wain J.C., Christiani D.C. A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States). Cancer Causes Control. 8:1997;544-553.
8. Harries L.W., Stubbins J., Forman D., Howard G.C.W., Wolf C.R. Identification of genetic polymorphism at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 18:1997;641-644.
9. Hayashi S., Watanabe J., Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Mu-class glutathione S-transferase genes. Jpn. J. Cancer Res. 83:1992;866-887.
10. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isozymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30:1995;445-600.
11. Helzlsouer K.J., Selmin O., Huang H-Y., Strickland P.T., Hoffman S., Alberg A.J., Watson M., Comstock G.W., Bell D.A. Association between glutathione S-transferase M1, P1 and T1 genetic polymorphisms and development of breast cancer. J. Natl. Cancer Inst. 90:1998;512-518.
12. Hirvonen A., Husgafvel-Pursiainen K., Anttila S., Vainio H. The GSTM1 null genotype as potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis. 14:1993;1479-1481.
13. Jourenkova N., Reinikainen M., Bouchardy C., Dayer P., Benhamou S., Hirvonen A. Larynx cancer risk in relation to glutathione S-transferase M1 and T1 genotypes and tobacco smoking. Cancer Epidemiol. Biomarkers Prev. 7:1998;19-23.
14. Ketterer B., Harris J.M., Talaska G., Meyer D.J., Pemble S.E., Taylor J.B., Lang N.P., Kadlubar F.F. The glutathione S-transferase supergene family, its polymorphism and effects on susceptibility to lung cancer. Environ. Health Perspect. 98:1992;87-94.
15. Kihara M., Kihara M., Noda K. Risk of smoking for squamous and small cell carcinoma of the lung modulated by combination of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis. 16:1995;2331-2336.
16. Kihara M., Kihara M., Kubota A., Furukawa M., Kimura H. GSTM1 gene polymorphism as a possible marker for susceptibility to head and neck cancers among Japanese smokers. Cancer Lett. 112:1997;257-262.
17. Lafuente A., Pujol F., Carretero P., Villa J.P., Cuchi A. Human glutathione S-transferase m (GSTm) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett. 68:1993;49-54.
18. Li D., Wang M., Dhingra K., Hittelman W.N. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res. 56:1996;287-293.
19. Lin H.J., Han C.-Y., Bernstein D.A., Hsiao W., Lin B.K., Hardy S. Ethnic distribution of the glutathione transferase Mu 1-1(GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis. 15:1994;1077-1081.
20. London S.J., Daly A.K., Cooper J., Navidi W.C., Carpenter C.L., Idle J.R. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African Americans and Caucasians in Los Angeles county, California. J. Natl. Cancer Inst. 87:1995;1246-1253.
21. Mannervik B., Alin P., Guthenberg C., Jensson H., Tahir M.K., Warholm M., Jornvall H. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc. Natl. Acad. Sci. USA. 82:1985;7202-7206.
22. Mannervik B., Danielson U.H. Glutathione transferases structure and catalytic activity. Crit. Rev. Biochem. Mol. Biol. 23:1988;281-284.
23. Mannervik B., Awasthi Y.B., Board P.G., Hayes J.D., Di Ilio C., Ketterer B., Listowsky I., Morgenstern R., Muramatsu M., Pearson W.R., Pickett C.B., Sato K., Widersten M., Wolf C.R. Nomenclature for human glutathione transferase. Biochem. J. 282:1992;305-306.
24. Meyer D.J., Coles B., Pemble S.E., Gilmore K.S., Fraser G.M., Ketterer B. Theta, a new class of glutathione transferases purified from rat and man. Biochem. J. 274:1991;409-414.
25. Nakachi K., Imai K., Hayashi S., Kawajiri K. Polymorphism of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in Japanese population. Cancer Res. 53:1993;2994-2999.
26. Nakajima T., Elovaara E., Anttila S., Hirvonen A., Camus A., Hayes J.D., Ketterer B., Vainio H. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis. 16:1995;707-711.
27. Nazar-Stewart V., Motulsky A.G., Eaton D.L., White E., Hornung S.K., Leng Z.T., Stapleton P., Weiss N.S. The glutathione S-transferase μ polymorphism as a marker for susceptibility to lung cancer. Cancer Res. 53:1993;2313-2318.
28. Nebert D.W. Role of genetics and drug metabolism in human cancer risk. Mutat. Res. 247:1991;267-281.
29. Park J.Y., Muscat J.E., Ren Q., Schantz S.P., Harwick R.D., Stern J.C., Pike V., Richie J.P., Lazarus P. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol. Biomarkers Prev. 6:1997;791-797.
30. Perera F.P., Estabrook A., Hewer A., Channing K., Rundle A., Mooley L.A., et al. Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol. Biomarkers Prev. 4:1995;233-238.
31. Ryberg D., Skaug V., Hewer A., Phillips D.H., Harries L.W., Wolf C.R., Ogreid D., Ulvik A., Vu P., Haugen A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 18:1997;1285-1289.
32. Seidegard J., Pero R.W., Mrkowitz M.M., Roush G., Miller D.G., Beattie E.J. Isozyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: follow up study. Carcinogenesis. 11:1990;33-36.
33. Trizna Z., Clayman G.L., Spitz M.R., Briggs K.L., Goepfert H. Glutathione S-transferase genotypes as risk factors for head and neck cancer. Am. J. Surg. 170:1995;499-501.
34. Watson M.A., Stewart R., Smith G., Massey T.E., Bell D.A. Glutathione S-transferase P1 polymorphism: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. 19:1998;275-280.
35. Zhong S., Howie A.F., Ketterer B., Taylor J., Hayes J.D., Beckett G.J., Wathen C.G., Wolf C.R., Spurr N.K. Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis. 12:1991;1533-1537.
36. Zhong S., Wyllie A.H., Barnes D., Wolf C.R., Spurr N.K. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis. 14:1993;1821-1824.
37. Zimniak P., Nandur B., Pikula S., Bandorowicz-Pikula J., Singhal S.S., Srivastava S.K., Awasthi S., Awasthi Y.C. Naturally occurring human glutathione S-transferase GSTP-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur. J. Biochem. 224:1994;893-899.